Sagimet Biosciences (SGMT) Amortizatization of Intangibles (2022 - 2026)

Sagimet Biosciences (SGMT) recorded quarterly Amortizatization of Intangibles of $140000.0 in Q1 2026, up 146.67% quarter-over-quarter from -$300000.0 in Q4 2025, and down 73.83% on a YoY basis from $535000.0 in Q1 2025.

Sagimet Biosciences (SGMT) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Sagimet Biosciences' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $140000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 73.83% year-over-year to $140000.0; the TTM figure through Mar 2026 stood at -$6000.0 (down 100.38% YoY), while the FY2025 annual figure was $389000.0, down 68.95% from the prior year.
  • Amortizatization of Intangibles was $140000.0 for Q1 2026 at Sagimet Biosciences, up from -$300000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $535000.0 in Q1 2025 to a low of -$300000.0 in Q4 2025.
  • Historically, Amortizatization of Intangibles has averaged $142142.9 across 5 years, with a median of $85500.0 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles soared 11825.0% in 2024, then tumbled 635.71% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $83000.0 in 2022, then slumped by 102.41% to -$2000.0 in 2023, then jumped by 2900.0% to $56000.0 in 2024, then sank by 635.71% to -$300000.0 in 2025, then jumped by 146.67% to $140000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $140000.0 (Q1 2026), -$300000.0 (Q4 2025), and -$72000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 13,267.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Sagimet Biosciences 211.96 Mn 211.96 Mn - 140,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 140,000.00
Mar 31, 2026 140,000.00
Dec 31, 2025 -300,000.00
Dec 31, 2025 -300,000.00
Sep 30, 2025 -72,000.00
Sep 30, 2025 -72,000.00
Jun 30, 2025 226,000.00
Jun 30, 2025 226,000.00
Mar 31, 2025 535,000.00
Mar 31, 2025 535,000.00
Dec 31, 2024 56,000.00
Dec 31, 2024 56,000.00
Sep 30, 2024 527,000.00
Sep 30, 2024 527,000.00
Jun 30, 2024 477,000.00
Jun 30, 2024 477,000.00
Mar 31, 2024 193,000.00
Mar 31, 2024 193,000.00
Dec 31, 2023 -2,000.00
Dec 31, 2023 -2,000.00